Abstract
Reported are three children with MS who responded dramatically to interferon-β (IFNβ) therapy. While on immunomodulatory therapy, they developed chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) that responded to IV immunoglobulin (IVIG) administration. These cases emphasize two interesting observations: 1) IFNβ treatment did not prevent development of CIDP; 2) CIDP in the context of MS responded to IVIG, even though IVIG had no therapeutic effect on the central demyelinating disease.
Original language | English (US) |
---|---|
Pages (from-to) | 1697-1699 |
Number of pages | 3 |
Journal | Neurology |
Volume | 60 |
Issue number | 10 |
DOIs | |
State | Published - May 27 2003 |
ASJC Scopus subject areas
- Clinical Neurology